102 related articles for article (PubMed ID: 34845197)
1. Untangling the Role of Polycomb Complexes in Chemotherapy Resistance.
Duy C; Melnick A
Cancer Discov; 2018 Nov; 8(11):1348-1351. PubMed ID: 30385522
[No Abstract] [Full Text] [Related]
2. Hypoxia-induced RBBP7 promotes esophagus cancer progression by inducing CDK4 expression.
Wang R; Huang Z; Lin Z; Chen B; Pang X; Du C; Fan H
Acta Biochim Biophys Sin (Shanghai); 2022 Feb; 54(2):179-186. PubMed ID: 35538026
[TBL] [Abstract][Full Text] [Related]
3. RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis.
Yin X; Teng X; Ma T; Yang T; Zhang J; Huo M; Liu W; Yang Y; Yuan B; Yu H; Huang W; Wang Y
Cell Death Differ; 2022 Nov; 29(11):2203-2217. PubMed ID: 35534547
[TBL] [Abstract][Full Text] [Related]
4. Interpreting the molecular mechanisms of RBBP4/7 and their roles in human diseases (Review).
Zhan Y; Yin A; Su X; Tang N; Zhang Z; Chen Y; Wang W; Wang J
Int J Mol Med; 2024 May; 53(5):. PubMed ID: 38577935
[TBL] [Abstract][Full Text] [Related]
5. The PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2.
Longhurst AD; Wang K; Suresh HG; Ketavarapu M; Ward HN; Jones IR; Narayan V; Hundley FV; Hassan AZ; Boone C; Myers CL; Shen Y; Ramani V; Andrews BJ; Toczyski DP
bioRxiv; 2024 Mar; ():. PubMed ID: 38562687
[TBL] [Abstract][Full Text] [Related]
6. Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2.
Ngubo M; Moradi F; Ito CY; Stanford WL
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895228
[TBL] [Abstract][Full Text] [Related]
7. RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer.
Prokakis E; Jansari S; Boshnakovska A; Wiese M; Kusch K; Kramm C; Dullin C; Rehling P; Glatzel M; Pantel K; Wikman H; Johnsen SA; Gallwas J; Wegwitz F
Cell Death Dis; 2023 Sep; 14(9):641. PubMed ID: 37770435
[TBL] [Abstract][Full Text] [Related]
8. Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways.
Liu L; Xiao B; Hirukawa A; Smith HW; Zuo D; Sanguin-Gendreau V; McCaffrey L; Nam AJ; Muller WJ
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2303010120. PubMed ID: 37549258
[TBL] [Abstract][Full Text] [Related]
9. Polycomb-like Proteins in Gene Regulation and Cancer.
Fischer S; Liefke R
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107696
[TBL] [Abstract][Full Text] [Related]
10. ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness.
Werner M; Dyas A; Parfentev I; Schmidt GE; Mieczkowska IK; Müller-Kirschbaum LC; Müller C; Kalkhof S; Reinhardt O; Urlaub H; Alves F; Gallwas J; Prokakis E; Wegwitz F
Cell Death Dis; 2022 Sep; 13(9):762. PubMed ID: 36057630
[TBL] [Abstract][Full Text] [Related]
11. PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ.
Yu H; Simons DL; Segall I; Carcamo-Cavazos V; Schwartz EJ; Yan N; Zuckerman NS; Dirbas FM; Johnson DL; Holmes SP; Lee PP
PLoS One; 2012; 7(12):e51239. PubMed ID: 23251464
[TBL] [Abstract][Full Text] [Related]
12. Morphine leads to global genome changes in H3K27me3 levels via a Polycomb Repressive Complex 2 (PRC2) self-regulatory mechanism in mESCs.
Muñoa-Hoyos I; Halsall JA; Araolaza M; Ward C; Garcia I; Urizar-Arenaza I; Gianzo M; Garcia P; Turner B; Subirán N
Clin Epigenetics; 2020 Nov; 12(1):170. PubMed ID: 33168052
[TBL] [Abstract][Full Text] [Related]
13. Mutations and deletions of PRC2 in prostate cancer.
Jain P; Di Croce L
Bioessays; 2016 May; 38(5):446-54. PubMed ID: 27000413
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond.
Deb G; Thakur VS; Gupta S
Epigenetics; 2013 May; 8(5):464-76. PubMed ID: 23644490
[TBL] [Abstract][Full Text] [Related]
15. Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Mieczkowska IK; Pantelaiou-Prokaki G; Prokakis E; Schmidt GE; Müller-Kirschbaum LC; Werner M; Sen M; Velychko T; Jannasch K; Dullin C; Napp J; Pantel K; Wikman H; Wiese M; Kramm CM; Alves F; Wegwitz F
Cell Death Dis; 2021 Nov; 12(12):1118. PubMed ID: 34845197
[TBL] [Abstract][Full Text] [Related]
16. HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer.
Pantelaiou-Prokaki G; Mieczkowska I; Schmidt GE; Fritzsche S; Prokakis E; Gallwas J; Wegwitz F
Clin Epigenetics; 2022 Jan; 14(1):7. PubMed ID: 35016723
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
